Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
60 Cards in this Set
- Front
- Back
2 types of breast carcinoma in situ? |
Lobar (LCIS) Ductal (DCIS) |
|
Where does the carcinoma in situ arise? |
Terminal ductal lobular unit (TDLU) |
|
Histological feature of LCIS |
- maintains TDLU architecture - fills and expands acini - small, monomorphic cells - bland, discohesive cells - no calcification or necrosis |
|
Histological features of DCIS |
- distant or unfolds TDLU - look like a duct(s) - COMEDO: pleomorphic/ high grade, central necrosis - NON COMEDO: calcified, cribiform (cookie cutter shape), solid |
|
Benign disorders of growth in BC |
-fibrocystic disease - sclerosing adenosis |
|
benign neoplasia of BC |
- fibroadenoma |
|
malignant neoplasia |
-DCIS - LCIS - Invasive Lobular - Invasive Ductal (NOS/NTS) |
|
What is a cyst? |
- epithelial lined sac containing proteinaceous fluid - distinctly eosinophilic cytoplasm (apocrine metaplasia) |
|
what is a blue domed cyst? |
large cysts which may appear blue/brown due to turbid fluid |
|
whats is fibrosis? |
increased fibrous tissue (collagen) - may cause chronic inflammation and scarring due to cyst leakage - may result in sclerosis (hardening) |
|
what is adenosis? |
increased no. of acini per lobule |
|
what are the constituents of fibrocystic change? |
fibrosis - increased stromal fibrous tissue cysts formation- dilatation of ducts, unfolding lobules apocrine metaplasia |
|
fibrocystic change in the breast is: |
-lumpy, bumpy breasts +- mastalgia - very common - hormone responsive |
|
2 kinds of fibrocystic change: |
1. Simple: no epithelial hyperplasia (no increased cancer risk) 2. Proliferative: epithelial hyperplasia - lumen filled with heterogenous luminal and myoepithelial cells - irregular, slit-like fenestrations - cancer risk increases with increase proliferation |
|
4 classes of fibrocystic change |
- mild - moderate - severe - atypical |
|
what does fibrocystic change look like on a mammogram? |
microcalcifications |
|
what is sclerosing adenosis? |
Intralobular fibrosis - may compress acini in centre, usually dilated at periphery - may mimic cancer-stromal fibrosis completely compress lumens - solid cords of cells |
|
What in the breast can sometimes be misdiagnosed for breast cancer? |
sclerosing adenosis |
|
what is a fibroadenoma? |
-benign neoplasm of interlobular fibroblasts (monoclonal fibroblastic stroma) - hyperplasia/ proliferation of ducts = adenosis |
|
what does a fibroadenoma look like? |
-well circumscribed - rubbery-rapid growth compresses surrounding tissue - freely mobile "breast mice" |
|
fibroadenomas are: |
- hormone responsive - most common benign breast tumour in 20-30yo |
|
breast cancer epidemiology |
- most commonly diagnosed cancer in Aust women (exc non-melanoma skin ca) - 2nd most common of cancer related death in women |
|
breast cancer risk factors: |
- age -age at menarche - age at first live birth - first degree relatives with breast cancer - atypical hyperplasia - race/ethnicity (non-hispanic white @highest risk) - oestrogen exposure - breast density - radiation exposure - obesity -breast feeding (protective) - geography / location |
|
Breast Carcinogenesis: |
|
|
Where is DCIS usually located? |
one quadrant one breast |
|
Where is LCIS usually located? |
multifocal bilateral (20-40%) |
|
Is e-cadherin present in IHC for LCIS? |
no |
|
Is e-cadherin present in IHC for DCIS? |
yes |
|
DCIS presentation |
usually asymptomatic - rarely a breast lump - Pagget's Disease (unilateral) --> red, scaly nipple |
|
LCIS presentation |
Asymptomatic - incidental finding on breast specimen |
|
Can LCIS be detected on mammography, if so how? |
No |
|
Can DCIS be detected on mammography, if so how? |
yes linear branching calcification |
|
what is the cancer risk per year for LCIS and DCIS? |
1% and accumalative |
|
What cancer can LCIS progress into? |
Lobular invasive Ductal Invasive |
|
What cancer can DCIS progress into? |
Ductal Invasive Other types |
|
Treatment options for LCIS: |
-careful followup --> screening (mammography)+ tamoxifin - bi-lateral mastectomy (prophylactic) |
|
Treatment options for DCIS: |
-wide local excision - radiotherapy |
|
What can eczema be mistaken for in the breast? |
Paggets Disease |
|
Incidence of Invasive Lobular Breast Cancer? |
20% |
|
Incidence of Invasive Ductal Breast Cancer? |
70-80% |
|
The histology of Invasive Lobular BC? |
- single file "indian file" - discohesive - encircle normal cells (targetoid) - signet ring cells (cytoplasmic mucin vacuole) - normal ducts visible within cancer lesion - +- desmoplasia |
|
The histology of Invasive Ductal BC? |
- heterogenous -tubules, cords, sheets, and nests - cohesive - strong desmoplastic response - no normal ducts within cancer lesion |
|
Is e- cadherin present in Invasive Lobular? |
no |
|
is e-caderin present in invasive ductal? |
yes |
|
receptors are in invasive lobular? |
ER +ve HER2 -ve |
|
receptors in invasive ductal? |
2/3 --> ER +ve, HER2 -ve 1/3 --> HER2 +ve |
|
what are the clinical presentations of invasive breast carcinoma? |
- breast lump/ pain
- nipple retraction/ discharge - peux d'orange - axillary lymph node involvement - mets - cachexia - fatigue |
|
signs of invasive BC in mammography? |
densely "stellate" (hard) |
|
possible met. location for invasive lobular? |
- CSF - Serosal surfacess - GIT - ovary -uterus - bone marrow |
|
possible met. location for invasive ductal? |
any site - lung -bone - liver - adrenal gland - brain |
|
possible treatment options for invasive BC? |
-Surgery +- chemotherapy +- hormonal therapy (ER +ve) +- radiotherapy (breast conservation surgery) +- Herceptin (HER2 +ve) |
|
genes involved in hereditary breast cancer? |
BRCA1/2 (3% of BC) tumour supressor/ DNA repair genes p53 Li Fraumeni Syndrome |
|
Diagnosing BC? |
TRIPLE ASSESSMENT: 1. Histology and Clinical Examination 2. Imaging 3. Tissue Biopsy |
|
There are 3 types of imaging 1. Mammography 2. Ultrasound 3. MRI When is each test appropriate to use? |
1. xray for elderly women 2. younger women 3. for those who have hereditary cancer |
|
Major prognostic factors |
- Invasive vs CIS - Mets - LN mets (worse with increase no.) - Tumour size - locally invasive - inflammatory cancer - invaded dermal lymphatics |
|
At which size, can a tumour be malignant? |
< likely to become malignant if <1cm (mammograms can pick this up) > likely to become malignant if between 2-3 cm (breast self-examination can detect this) |
|
Minor prognostic markers: |
- histological subtype (Ductal NOS worse) - Histological grade: well, mod, poorly differentiated - IHC (ER, PR) - HER2/neu gene amplification -lymph/vascular invasion - proliferative rate - DNA content - gene expression profile |
|
What is HER2/ neu? |
HER2 protein is a transmembrane glycoprotein in the epidermal growth factor receptor family -overexpressed in 20% of BC due to gene amplification |
|
HER2/neu is associated with: |
-poor outcome - high nuclear grade - poor response to hormonal therapy - HER2 targeted therapy (Herceptin- Her2 monoclonal antibody) |
|
Staging Breast cancer (AJCC): |
|